These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction. Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167 [TBL] [Abstract][Full Text] [Related]
6. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
7. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
8. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction. Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234 [TBL] [Abstract][Full Text] [Related]
9. Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study. Monassier JP; Hanssen M Drugs; 1987; 33 Suppl 3():282-5. PubMed ID: 3315608 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. Anderson JL J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369 [TBL] [Abstract][Full Text] [Related]
11. New developments in thrombolytic therapy. Collen DC; Gold HK Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114 [TBL] [Abstract][Full Text] [Related]
12. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Rothbard RL Drugs; 1987; 33 Suppl 3():276-8. PubMed ID: 3315606 [TBL] [Abstract][Full Text] [Related]
13. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction. Baxter-Jones CS; White HD; Anderson JL J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637 [TBL] [Abstract][Full Text] [Related]
14. Safety and tolerance data from the Belgian multicentre study of anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Bossaert LL Drugs; 1987; 33 Suppl 3():287-92. PubMed ID: 3315610 [TBL] [Abstract][Full Text] [Related]
15. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104 [TBL] [Abstract][Full Text] [Related]
16. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO. Bates ER Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479 [TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1. O'Connor CM; Meese R; Carney R; Smith J; Conn E; Burks J; Hartman C; Roark S; Shadoff N; Heard M J Am Coll Cardiol; 1994 Jan; 23(1):11-8. PubMed ID: 8277068 [TBL] [Abstract][Full Text] [Related]
19. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin. Croydon EA Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611 [TBL] [Abstract][Full Text] [Related]